NCT04040413 Database Maintenance for Bariatric Procedures
| NCT ID | NCT04040413 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sheba Medical Center |
| Condition | Obesity, Morbid |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2014-01-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2014-01-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Bariatric surgery registry for quality control and investigational purposes.
Eligibility Criteria
Inclusion Criteria: * morbid obesity Exclusion Criteria: * unfit for surgery
Frequently Asked Questions
Who can join the NCT04040413 clinical trial?
This trial is open to participants of all sexes, studying Obesity, Morbid. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04040413 currently recruiting?
Yes, NCT04040413 is actively recruiting participants. Visit ClinicalTrials.gov or contact Sheba Medical Center to inquire about joining.
Where is the NCT04040413 trial being conducted?
This trial is being conducted at Ramat Gan, Israel.
Who is sponsoring the NCT04040413 clinical trial?
NCT04040413 is sponsored by Sheba Medical Center. The trial plans to enroll 5,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.